↓ Skip to main content

Development of sotagliflozin, a dual sodium-dependent glucose transporter 1/2 inhibitor

Overview of attention for article published in Diabetes and Vascular Disease Research, February 2015
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#4 of 424)
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news
12 news outlets
twitter
1 X user
patent
6 patents
wikipedia
1 Wikipedia page

Readers on

mendeley
125 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Development of sotagliflozin, a dual sodium-dependent glucose transporter 1/2 inhibitor
Published in
Diabetes and Vascular Disease Research, February 2015
DOI 10.1177/1479164114563304
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 125 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Sweden 1 <1%
Russia 1 <1%
Croatia 1 <1%
Unknown 122 98%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Master 18 14%
Other 12 10%
Student > Ph. D. Student 12 10%
Student > Bachelor 11 9%
Researcher 10 8%
Other 22 18%
Unknown 40 32%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 34 27%
Pharmacology, Toxicology and Pharmaceutical Science 21 17%
Biochemistry, Genetics and Molecular Biology 8 6%
Agricultural and Biological Sciences 6 5%
Chemistry 4 3%
Other 8 6%
Unknown 44 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 106. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 September 2026.
All research outputs
#503,520
of 34,528,520 outputs
Outputs from Diabetes and Vascular Disease Research
#4
of 424 outputs
Outputs of similar age
#4,765
of 295,551 outputs
Outputs of similar age from Diabetes and Vascular Disease Research
#1
of 14 outputs
Altmetric has tracked 34,528,520 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 424 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.5. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 295,551 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.